Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs ALK✓SelectedUSD · ALKMRNA vs ALK performance historyLatest closeAs of-2.17%11/20
Stock and ETF performance explorer

MRNA vs ALK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-31.0%
ALK return
-36.6%
Excess return
+5.6%
Maximum drawdown
-93.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioALKExcessAlpha
1D-2.2%-5.9%+3.7%-0.4%
7D-12.7%-12.3%-0.4%-9.3%
30D-20.7%+0.6%-21.2%-20.9%
3M+46.3%-16.1%+62.3%+53.8%
6M+305.2%-15.4%+320.6%+318.3%
YTD+561.2%-32.9%+594.2%+621.1%
1Y+772.1%-10.8%+782.9%+763.2%
3Y+147.0%-9.6%+156.6%+123.0%
All-31.0%-36.6%+5.6%-29.7%

Cumulative growth

Daily Returns

Daily percentage return beside ALK.

Daily Out/Under-Performance

Portfolio return minus ALK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × ALK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded ALK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling